Featured Posts

Tuesday, February 5, 2019

NHS England Expands Loco-regional Treatment Options for Colorectal Cancer Patients With Metastatic Disease [1]

LONDON, Feb. 5, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), a global healthcare company, today announced that the NHS Specialised Services Commissioning Committee has agreed that, effective 1 April 2019, NHS England will routinely commission Selective Internal Radiation Therapy (SIRT) for...

from PR Newswire: https://prn.to/2RFB2oz

No comments:

Post a Comment